Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis

Código QR

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis

Clemens Warnke1,2, Olaf St&uuml;ve3,4, Hans-Peter Hartung1, Anna Fogdell-Hahn2, Bernd C Kieseier11Department of Neurology, Heinrich-Heine-University, D&uuml;sseldorf, Germany; 2Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; 3Department of Neurology, Dal...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Warnke C, St&uuml;ve O, Hartung HP, Fogdell-Hahn A, Kieseier B
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/1f40c5bda7594a358c550787481ca194
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Review of teriflunomide and its potential in the treatment of multiple sclerosis
por: Clemens Warnke, et al.
Publicado: (2009)

New treatment options for fibromyalgia: critical appraisal of duloxetine
por: Nurcan &Uuml;&ccedil;eyler, et al.
Publicado: (2008)

Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia
por: Reem Bunyan, et al.
Publicado: (2021)

Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients
por: Kimberley Allen-Philbey, et al.
Publicado: (2021)

The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results
por: Sandra Thiel, et al.
Publicado: (2021)

Critical appraisal of lurasidone in the management of schizophrenia
por: Caccia S, et al.
Publicado: (2012)

Measuring treatment response to advance precision medicine for multiple sclerosis
por: Peter A. Calabresi, et al.
Publicado: (2021)

A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis
por: Kerstin Hellwig, et al.
Publicado: (2021)

Association between smoking and cognitive impairment in multiple sclerosis
por: Özcan ME, et al.
Publicado: (2014)

Lymphomatoid papulosis in a patient treated with glatiramer acetate and the glatiramoid Glatopa for multiple sclerosis: A case report
por: Afsaneh Shirani, et al.
Publicado: (2021)

Disease-modifying therapies in relapsing&ndash;remitting multiple sclerosis
por: Fabricio Gonz&aacute;lez-Andrade, et al.
Publicado: (2010)

The Effect of Body Mass Index on Brain Volume and Cognitive Function in Relapsing–Remitting Multiple sclerosis: A CombiRx Secondary Analysis
por: Aliza Bitton Ben-Zacharia, et al.
Publicado: (2021)

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy
por: Gozes I, et al.
Publicado: (2012)

Humoral immune response and lymphocyte levels after complete vaccination against COVID-19 in a cohort of multiple sclerosis patients treated with cladribine tablets
por: Christoph Grothe, et al.
Publicado: (2021)

Cognitive dysfunction in pediatric multiple sclerosis
por: Suppiej A, et al.
Publicado: (2014)

The Multiple Sclerosis Treatment Optimization Program
por: Annette Langer‐Gould, et al.
Publicado: (2021)

Neurobehavioral burden of multiple sclerosis with nanotheranostics
por: Sriramoju B, et al.
Publicado: (2015)

Role of oral teriflunomide in the management of multiple sclerosis
por: Tanasescu R, et al.
Publicado: (2013)

Cannabinoids in the management of spasticity associated with multiple sclerosis
por: Anna Maria Malfitano, et al.
Publicado: (2008)

Impact of Andropause on Multiple Sclerosis
por: Maria C. Ysrraelit, et al.
Publicado: (2021)

The role of glatiramer acetate in the early treatment of multiple sclerosis
por: David W Brandes
Publicado: (2010)

Gut microbiome is associated with multiple sclerosis activity in children
por: Mary K. Horton, et al.
Publicado: (2021)

New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
por: Diana Domnitei, et al.
Publicado: (2010)

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
por: Lugaresi A, et al.
Publicado: (2013)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer&rsquo;s disease
por: Umamon Puangthong, et al.
Publicado: (2009)

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
por: Robert H Howland
Publicado: (2009)

Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab
por: Dubey D, et al.
Publicado: (2015)

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
por: Castrop F, et al.
Publicado: (2013)

Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis
por: Hayes KC
Publicado: (2011)

Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis
por: Babij R, et al.
Publicado: (2015)

Attention deficits in Japanese multiple sclerosis patients with minor brain lesion loads
por: Takeda A, et al.
Publicado: (2011)

Walking impairment in patients with multiple sclerosis: exercise training as a treatment option
por: Robert W Motl, et al.
Publicado: (2010)

Pareidolia in Parkinson’s Disease and Multiple System Atrophy
por: Kentaro Kurumada, et al.
Publicado: (2021)

Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis
por: Julie A Murphy, et al.
Publicado: (2010)

Cluster headache as a first manifestation of multiple sclerosis: case report and literature review
por: Mijajlović MD, et al.
Publicado: (2014)

The role of microglia in multiple sclerosis
por: Luo C, et al.
Publicado: (2017)

When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis
por: Kachuck NJ
Publicado: (2011)

Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity
por: Veauthier C, et al.
Publicado: (2015)

Multiple Cranial Nerve Palsies in a Pediatric Case of Lemierre’s Syndrome due to Streptococcus viridans
por: Samantha Novotny, et al.
Publicado: (2021)

Review of the clinical evidence for interferon &beta; 1a (Rebif&reg;) in the treatment of multiple sclerosis
por: Francesco Manfredonia, et al.
Publicado: (2008)